Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

Similar articles for PubMed (Select 23216238)

1.

The ultrastructural difference between CD133-positive U251 glioma stem cells and normal U251 glioma cells.

Yang B, Wang Y, Yang C, Ouyang W, Zhou F, Zhou Y, Xie C.

Ultrastruct Pathol. 2012 Dec;36(6):404-8. doi: 10.3109/01913123.2012.708011.

PMID:
23216238
2.

Enhanced invasion in vitro and the distribution patterns in vivo of CD133+ glioma stem cells.

Yu SP, Yang XJ, Zhang B, Ming HL, Chen C, Ren BC, Liu ZF, Liu B.

Chin Med J (Engl). 2011 Sep;124(17):2599-604.

PMID:
22040410
3.

B7-H4 expression is elevated in human U251 glioma stem-like cells and is inducible in monocytes cultured with U251 stem-like cell conditioned medium.

Mo LJ, Ye HX, Mao Y, Yao Y, Zhang JM.

Chin J Cancer. 2013 Dec;32(12):653-60. doi: 10.5732/cjc.012.10228. Epub 2013 Jan 18.

4.

Using CD133 positive U251 glioblastoma stem cells to establish nude mice model of transplanted tumor.

Jin F, Gao C, Zhao L, Zhang H, Wang HT, Shao T, Zhang SL, Wei YJ, Jiang XB, Zhou YP, Zhao HY.

Brain Res. 2011 Jan 12;1368:82-90. doi: 10.1016/j.brainres.2010.10.051. Epub 2010 Oct 21.

PMID:
20971095
5.

Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.

Huang Q, Zhang QB, Dong J, Wu YY, Shen YT, Zhao YD, Zhu YD, Diao Y, Wang AD, Lan Q.

BMC Cancer. 2008 Oct 22;8:304. doi: 10.1186/1471-2407-8-304.

6.

A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.

Kim RK, Kim MJ, Yoon CH, Lim EJ, Yoo KC, Lee GH, Kim YH, Kim H, Jin YB, Lee YJ, Cho CG, Oh YS, Gye MC, Suh Y, Lee SJ.

Mol Pharmacol. 2012 Sep;82(3):400-7. doi: 10.1124/mol.112.078402. Epub 2012 May 30.

7.

The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.

Ping YF, Yao XH, Jiang JY, Zhao LT, Yu SC, Jiang T, Lin MC, Chen JH, Wang B, Zhang R, Cui YH, Qian C, Wang Jm, Bian XW.

J Pathol. 2011 Jul;224(3):344-54. doi: 10.1002/path.2908. Epub 2011 May 27.

PMID:
21618540
8.

The utility and limitations of neurosphere assay, CD133 immunophenotyping and side population assay in glioma stem cell research.

Wan F, Zhang S, Xie R, Gao B, Campos B, Herold-Mende C, Lei T.

Brain Pathol. 2010 Sep;20(5):877-89. doi: 10.1111/j.1750-3639.2010.00379.x. Epub 2010 Feb 5. Review.

PMID:
20331619
9.

The different HMGA1 expression of total population of glioblastoma cell line U251 and glioma stem cells isolated from U251.

Fan H, Guo H, Zhang IY, Liu B, Luan L, Xu S, Hou X, Liu W, Zhang R, Wang X, Pang Q.

Brain Res. 2011 Apr 12;1384:9-14. doi: 10.1016/j.brainres.2011.01.105. Epub 2011 Feb 25.

PMID:
21300033
10.

MiR-125b is critical for the suppression of human U251 glioma stem cell proliferation.

Shi L, Zhang J, Pan T, Zhou J, Gong W, Liu N, Fu Z, You Y.

Brain Res. 2010 Feb 2;1312:120-6. doi: 10.1016/j.brainres.2009.11.056. Epub 2009 Nov 27.

PMID:
19948152
11.

Rac1+ cells distributed in accordance with CD 133+ cells in glioblastomas and the elevated invasiveness of CD 133+ glioma cells with higher Rac1 activity.

Zhang B, Sun J, Yu SP, Chen C, Liu B, Liu ZF, Ren BC, Ming HL, Yang XJ.

Chin Med J (Engl). 2012 Dec;125(24):4344-8.

PMID:
23253699
12.

Cell surface Nestin is a biomarker for glioma stem cells.

Jin X, Jin X, Jung JE, Beck S, Kim H.

Biochem Biophys Res Commun. 2013 Apr 19;433(4):496-501. doi: 10.1016/j.bbrc.2013.03.021. Epub 2013 Mar 21.

PMID:
23524267
13.

Expansion of CD133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy.

Tamura K, Aoyagi M, Ando N, Ogishima T, Wakimoto H, Yamamoto M, Ohno K.

J Neurosurg. 2013 Nov;119(5):1145-55. doi: 10.3171/2013.7.JNS122417. Epub 2013 Aug 30.

PMID:
23991844
14.

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN.

Nature. 2006 Dec 7;444(7120):756-60. Epub 2006 Oct 18.

PMID:
17051156
15.

Influence of Etoposide on anti-apoptotic and multidrug resistance-associated protein genes in CD133 positive U251 glioblastoma stem-like cells.

Jin F, Zhao L, Guo YJ, Zhao WJ, Zhang H, Wang HT, Shao T, Zhang SL, Wei YJ, Feng J, Jiang XB, Zhao HY.

Brain Res. 2010 Jun 8;1336:103-11. doi: 10.1016/j.brainres.2010.04.005. Epub 2010 Apr 11.

PMID:
20388502
16.

Non-invasive in vivo imaging of tumor-associated CD133/prominin.

Tsurumi C, Esser N, Firat E, Gaedicke S, Follo M, Behe M, Elsässer-Beile U, Grosu AL, Graeser R, Niedermann G.

PLoS One. 2010 Dec 20;5(12):e15605. doi: 10.1371/journal.pone.0015605.

17.

Type 1 collagen as a potential niche component for CD133-positive glioblastoma cells.

Motegi H, Kamoshima Y, Terasaka S, Kobayashi H, Houkin K.

Neuropathology. 2014 Aug;34(4):378-85. doi: 10.1111/neup.12117. Epub 2014 Mar 27.

PMID:
24673436
18.

[Correlative study of distribution of brain tumor stem cell with micro-vascular system].

Li MW, Niu CS.

Zhonghua Yi Xue Za Zhi. 2010 Feb 2;90(5):305-9. Chinese.

PMID:
20368050
19.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk